PLAYSTUDIOS, Inc. MYPS
0.48
0.03
6.67%
as of 25 Sep
- Market cap
- $53.6M
- P/E
- 0.0×
Follow MYPS
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.28 | 0.26 | 0.35 | 0.49 | |
P/FCF ratio |
27.09 | 6.14 | 8.30 | 6.83 | |
P/Operating CF |
11.32 | 16.14 | 21.85 | 21.32 | |
P/B ratio |
0.31 | 0.27 | 0.36 | 0.51 | |
Price to Tangible BV |
0.72 | 0.63 | 0.82 | 1.13 | |
EV/Sales |
(0.17) | (0.19) | (0.10) | 0.06 | |
EV/EBITDA |
23.71 | 0.00 | 0.00 | 4.74 | |
EV/Operating CF |
(2.07) | (1.63) | (0.88) | 0.42 | |
EV/FCF |
(16.50) | (4.47) | (2.36) | 0.81 | |
Quick Ratio |
2.86 | 2.87 | 2.96 | 3.68 | |
Current Ratio |
2.99 | 3.04 | 3.12 | 3.91 | |
Net Debt/EBITDA |
(641.68) | 29.86 | 628.35 | (57.78) | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.77 | 0.77 | 0.77 | 0.79 | |
Operating CF/Net income |
(0.42) | (0.35) | (0.27) | (0.62) | |
Capex/Depreciation |
(0.39) | (0.41) | (0.43) | (0.45) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
27.54% | 25.21% | 28.29% | 25.70% | |
Selling, General and Administrative Expense of Revenue |
43.78% | 52.15% | 46.22% | 45.52% | |
Intangible Assets out of Total Assets |
0.44 | 0.44 | 0.44 | 0.44 | |
Share Based Compensation of Revenue |
4.28% | 4.08% | 4.06% | 5.26% | |
Graham Net Nets |
1.05 | 1.18 | 0.88 | 0.65 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(72.00%) | (59.57%) | (33.85%) | (30.21%) | |
Free Cash Flow Yield |
3.69% | 16.29% | 12.05% | 14.64% | |
Revenue per Share |
0.43 | 0.46 | 0.44 | 0.46 | |
Operating CF per Share |
0.04 | 0.03 | 0.03 | 0.05 | |
Capex per Share |
(0.03) | (0.03) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.01 | 0.00 | 0.00 | 0.01 | |
Cash per Share |
0.80 | 0.81 | 0.83 | 0.85 | |
Shareholders Equity per Share |
1.63 | 1.72 | 1.81 | 1.90 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
1.63 | 1.72 | 1.81 | 1.90 | |
Free Cash Flow |
1.82 | (0.35) | (0.39) | 1.29 | |
Working Capital |
86.81 | 89.81 | 91.59 | 103.09 | |
Capital Expenditures |
(3.82) | (4.07) | (4.13) | (4.37) | |
Net Current Asset Value |
66.91 | 70.76 | 72.02 | 78.31 | |
EV/EBIT |
0.96 | 1.27 | 0.97 | 0.00 | |
Capex to Sales |
0.07 | 0.07 | 0.07 | 0.08 | |
Net Profit Margin |
(24.14%) | (18.28%) | (24.72%) | (15.82%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
25.32 | 26.22 | 26.79 | 26.46 | |
Average Payables |
5.90 | 7.43 | 4.66 | 4.70 | |
Average Assets |
293.69 | 298.10 | 306.79 | 314.85 | |
Average Common Equity |
226.49 | 231.70 | 236.29 | 252.05 |
Columns are period end dates